0000000000199452

AUTHOR

Giampaolo Perna

0000-0002-8166-0785

showing 8 related works from this author

The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions

2017

Cardio-vascular diseases (CVDs) and CVD-related disorders (including cerebrovascular diseases; CBVDs) are a major public health concern as they represent the leading cause of mortality and morbidity in developed countries. Patients with CVDs and CBVDs co-morbid with mood disorders, especially bipolar disorder (BD) and major depressive disorder (MDD), suffer reduced quality-of-life and significant disability adjusted for years of life and mortality. The relationship between CVDs/CBVDs and mood disorders is likely to be bidirectional. Evidence for shared genetic risk of pathways involved in stress reaction, serotonin or dopamine signalling, circadian rhythms, and energy balance was reported i…

cognitionmedicine.medical_specialtyPsychological interventionphysical activity03 medical and health sciences0302 clinical medicineNeurobiologycardiovascular diseasemental disordersmedicineHumansBipolar disorderPsychiatrybipolar disorderpsychopharmacologyexerciseMood DisordersDepression; bipolar disorder; cardiovascular disease; cognition; comorbidity; exercise; physical activity; psychopharmacology; quality-of-life; strokeDepressionmedicine.diseaseComorbiditystroke030227 psychiatryCerebrovascular DisordersPsychiatry and Mental healthcomorbidityMoodHypomaniaMood disordersquality-of-lifeMajor depressive disordermedicine.symptomPsychologybipolar disorder; cardiovascular disease; cognition; comorbidity; Depression; exercise; physical activity; psychopharmacology; quality-of-life; strokeMania030217 neurology & neurosurgeryClinical psychology
researchProduct

Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly …

2016

Michele Fornaro,1,2 Marco Solmi,3–5 Giampaolo Perna,2,6 Domenico De Berardis,2,7 Nicola Veronese,5,8 Laura Orsolini,2,9 Licinia Ganança,1,10 Brendon Stubbs11,12 1New York State Psychiatric Institute, Columbia University, New York City, NY, USA; 2Polyedra Research Group®, Ascoli, 3Department of Neurosciences, University of Padua, 4Department of Mental Health, National Health Service, Padova, 5IREM Institute for Clinical Research and Education in Medicine, Padova, 6Department of Clinical Neurosciences, Hermanas Hospitalarias – Villa San Benedetto Menni Hospital, FoRiPsi, Albese con Cassano, Como, 7Department of Mental Health, Psychiatric Service of Diagn…

Moderate to severemedicine.medical_specialtyNeuropsychiatric Disease and TreatmentNeurosciences. Biological psychiatry. Neuropsychiatrymeta-analysis.Placebolisdexamfetaminemeta-analysilaw.inventionFood and drug administration03 medical and health sciencessystematic-review0302 clinical medicineRandomized controlled trialsystematic reviewBinge-eating disorderlawmedicinebinge eating disorderlisdexamfetamine binge eating disorder systematic review meta-analysisPsychiatryRC346-429Original Researchbusiness.industrydigestive oral and skin physiologymedicine.disease030227 psychiatrymeta-analysisLisdexamfetamineMeta-analysisbinge eating disorder; lisdexamfetamine; meta-analysis; systematic reviewNeurology. Diseases of the nervous systembusiness030217 neurology & neurosurgerymedicine.drugRC321-571Neuropsychiatric disease and treatment
researchProduct

Effect of the serotonin transporter gene and of environment on the continuity of anxiety and depression traits throughout adolescence

2014

Aims.Many studies of various stress reactive phenotypes suggest that 5-HTTLPR short allele carriers (S-carriers) are characterised by the stable trait of negative affectivity that is converted to psychopathology only under conditions of stress. In this study, we examined the moderating role of the 5-HTTLPR on the relationship between two objective chronic risk factors, i.e. socioeconomic status (SES) and family structure, and internalising symptoms across adolescence.Methods.A multigroup path analysis was employed in a general adolescent population sample of a 5-year follow-up study.Results.Internalising problems were significantly more stable in theS-carriers. The focus on the main dimensi…

Settore M-PSI/01 - Psicologia GeneraleEpidemiologyAdolescence Child Behaviour Checklist environmental adversities internalising problems serotonin transporter.Negative affectivityDevelopmental psychologymedicineAllelePath analysis (statistics)Socioeconomic statusSerotonin transporterChild Behaviour Checklistbiologyenvironmental adversitiesserotonin transporterPublic Health Environmental and Occupational HealthInternalising problemOriginal ArticlesAdolescencePsychiatry and Mental healthEnvironmental adversitiebiology.proteinTraitAnxietyinternalising problemsmedicine.symptomPsychologyPsychopathologyEpidemiology and Psychiatric Sciences
researchProduct

Does the “Silver Bullet” Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients.

2016

Background:Though often perceived as a “silver bullet” treatment for bipolar disorder (BD), lithium has seldom reported to lose its efficacy over the time.Objective:The aim of the present study was to assess cases of refractoriness toward restarted lithium in BD patients who failed to preserve maintenance.Method:Treatment trajectories associated with re-instituted lithium following loss of achieved lithium-based maintenance in BD were retrospectively reviewed for 37 BD-I patients (median age 52 years; F:M=17:20 or 46% of the total) over an 8.1-month period on average.Results:In our sample only 4 cases (roughly 11% of the total, of whom F:M=2:2) developed refractoriness towards lithium after…

medicine.medical_specialtyPediatricsLithium (medication)EpidemiologyRefractory periodMaintenanceDiscontinuation03 medical and health sciences0302 clinical medicinemedicineClinical significanceBipolar disorderDiscontinuation Maintenance Refractoriness TolerancePsychiatryHigh rateSignificant differencemedicine.disease030227 psychiatryDiscontinuationPsychiatry and Mental healthProspective researchPsychologyRefractorineTolerance030217 neurology & neurosurgerymedicine.drug
researchProduct

The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis

2016

Introduction Data about the prevalence of borderline personality (BPD) and bipolar (BD) disorders comorbidity are scarce and the boundaries remain controversial. We conducted a systematic review and meta-analysis investigating the prevalence of BPD in BD and BD in people with BPD. Methods Two independent authors searched MEDLINE, Embase, PsycINFO and the Cochrane Library from inception till November 4, 2015. Articles reporting the prevalence of BPD and BD were included. A random effects meta-analysis and meta-regression were conducted. Results Overall, 42 papers were included: 28 considering BPD in BD and 14 considering BD in BPD. The trim and fill adjusted analysis demonstrated the prevale…

medicine.medical_specialtyBipolar Disordermedia_common.quotation_subjectMEDLINEbipolar (BD) disordersPsycINFOComorbidityCochrane LibraryBorderline personality disorder (BPD)behavioral disciplines and activitiesborderline personality (BPD03 medical and health sciences0302 clinical medicineBorderline Personality DisorderInternal medicinemental disordersmedicinePrevalencePersonalityHumansMeta-regressionMeta-analysimedia_commonPredictorsmedicine.diseaseBipolar disorder (BD)ComorbidityPersonality disorders030227 psychiatryBipolar disorder (BD); Borderline personality disorder (BPD); Comorbidity; Meta-analysis; Predictors; Prevalence; Systematic review; Psychiatry and Mental Health; Clinical PsychologyMeta-analysisClinical PsychologyPsychiatry and Mental HealthMeta-analysisSystematic reviewPsychology030217 neurology & neurosurgeryClinical psychologyPredictorHuman
researchProduct

Effect of family structure and TPH2 G-703T on the stability of dysregulation profile throughout adolescence

2015

Abstract Background Two different polymorphisms (TPH2 G-703T and 5-HTTLPR) involved in the serotonergic pathway have been reported to play a role, both alone and in interaction with the environment, in early and adult emotion regulation. As most of these studies are cross-sectional, we know little about the impact of these polymorphisms over time, particularly during adolescence. Methods Because we were interested in the effects of these polymorphisms and environment (i.e., family structure) at different time-points on the emotional dysregulation profile, we performed a path analysis model in a general adolescent population sample of a five-year follow-up study. Results We found a high stab…

Settore M-PSI/01 - Psicologia GeneraleMaleAdolescentGenotypeEmotional dysregulationTryptophan Hydroxylase5-HTTLPRSerotonergicDevelopmental psychologyDysregulation profileYoung Adult03 medical and health sciences0302 clinical medicinePolymorphism (computer science)TPH2HumansAffective SymptomsAlleleGene–environment interactionYoung adultAllelesTPH2; 5-HTTLPR; Emotional dysregulation; Adolescence; Family structure; Dysregulation profileSerotonin Plasma Membrane Transport ProteinsPolymorphism GeneticTPH2Emotional dysregulationAdolescence030227 psychiatryPsychiatry and Mental healthClinical Psychology5-HTTLPRFemaleGene-Environment InteractionFamily RelationsPsychologyFamily structure030217 neurology & neurosurgeryFollow-Up StudiesClinical psychologyJournal of Affective Disorders
researchProduct

Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews

2017

Introduction. A burgeoning number of systematic reviews considering lurasidone in the treatment of bipolar depression have occurred since its Food and Drug Administration extended approval in 2013. While a paucity of available quantitative evidence still precludes preliminary meta-analysis on the matter, the present quality assessment of systematic review of systematic reviews, nonetheless, aims at highlighting current essential information on the topic. Methods. Both published and unpublished systematic reviews about lurasidone mono- or adjunctive therapy in the treatment of bipolar depression were searched by two independent authors inquiring PubMed/Cochrane/Embase/Scopus from inception u…

Genetics and Molecular Biology (all)Transtorno Bipolarmedicine.medical_specialtyBipolar DisorderImmunology and Microbiology (all)ConcordanceDrug profileAlternative medicineMEDLINElcsh:MedicineReview ArticleBiochemistryGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesLurasidone Hydrochloride0302 clinical medicineImmunology and Microbiology (all); Biochemistry Genetics and Molecular Biology (all)medicineBipolar DepressionHumansPsychiatryDrug ApprovalDepression (differential diagnoses)LurasidoneGeneral Immunology and Microbiologybusiness.industrylcsh:RGeneral Medicine030227 psychiatrySystematic reviewTolerabilityDepressãobusiness030217 neurology & neurosurgerymedicine.drugLurasidone
researchProduct

Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placeb…

2016

Evidence supporting the use of second generation antipsychotics (SGAs) in the treatment of acute depression with mixed features (MFs) associated with bipolar disorder (BD) is scarce and equivocal. Therefore, we conducted a systematic review and preliminary meta-analysis investigating SGAs in the treatment of acute BD depression with MFs. Two authors independently searched major electronic databases from 1990 until September 2015 for randomized (placebo-) controlled trials (RCTs) or open-label clinical trials investigating the efficacy of SGAs in the treatment of acute bipolar depression with MFs. A random-effect meta-analysis calculating the standardized mean difference (SMD) between SGA an…

Bipolar DisorderManic-depressive illness--Treatmentmeta-analysilcsh:ChemistryClinical trials0302 clinical medicineManic-depressive illnessAsenapineAntipsychotic drugslcsh:QH301-705.5Spectroscopydiagnostic and statistical manual for mental disorders fifth edition (DSM-5)PsychiatryDepressionBrief ReportGeneral MedicineComputer Science ApplicationsTreatment OutcomeMeta-analysismixed featureHumanmedicine.drugAntipsychotic Agentsmedicine.medical_specialtyAcute bipolar depression; Diagnostic and statistical manual for mental disorders fifth edition (DSM-5); Meta-analysis; Mixed features; Second generation antipsychotic (SGA); Systematic-review; Physical and Theoretical Chemistry; Organic Chemistry; Spectroscopy; Inorganic Chemistry; Catalysis; Molecular BiologyYoung Mania Rating ScalePlaceboCatalysisInorganic Chemistry03 medical and health sciencessystematic-reviewInternal medicinemedicineHumansZiprasidoneBipolar disorderPhysical and Theoretical ChemistryPsychiatryMolecular BiologyLurasidonemixed featuresbusiness.industryOrganic Chemistrysecond generation antipsychotic (SGA)acute bipolar depressionmedicine.disease030227 psychiatrymeta-analysisAntipsychotic Agentlcsh:Biology (General)lcsh:QD1-999QuetiapineControlled Clinical Trials as Topicbusiness030217 neurology & neurosurgeryInternational Journal of Molecular Sciences
researchProduct